Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 8 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

50%

4 trials in Phase 3/4

Results Transparency

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 3

3(42.9%)

N/A

3(42.9%)

Phase 4

1(14.3%)

7Total

Phase 3(3)

N/A(3)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT00780754Phase 3Completed

Prevention of Prostate Cancer With Dutasteride in Case of High Grade PIN Neoplasia

Role: lead

NCT02999217Phase 4Unknown

Intravenous Iron for Correction of Anaemia After Colorectal Surgery

Role: lead

NCT02468388Not ApplicableCompleted

Re-mineralization Effects of Sugar Free Chewing Gum Sweetened With Different Sugar-substitutes

Role: collaborator

NCT00868543Phase 3Unknown

Long or Very Long-Limb Gastric Bypass in Superobese

Role: lead

NCT00631501Not ApplicableUnknown

Doxycycline for Lateral Epicondylalgia - RCT

Role: lead

NCT00597311Phase 3Unknown

Preoperative Chemoradiation Versus Short Term Radiation Alone With Delayed Surgery for Stage II and III Resectable Rectal Cancer

Role: lead

NCT00528476Completed

Risk Factors for Recurrent Urinary Tract Infection in Children

Role: lead

NCT00375687Not ApplicableUnknown

Investigation of Early Hormonotherapy Efficacy of Prostate Cancer

Role: lead

All 8 trials loaded